SysBio FAIRplex: a platform to explore systems biology data for adult-onset diabetes and related diseases
Official title: SysBio FAIRplex: a FAIR PLatform for EXploration of Systems Biology
Funded at Verily Life Sciences LLC · NIH-11533814 · Data updated 2026-11-12
A project to create an easy-to-use platform that brings together biomedical data from many sources to help researchers study adult-onset diabetes and related conditions.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Verily Life Sciences LLC NIH-funded |
| Lab location | 1 site (South San Francisco, United States) |
| Project start | September 27, 2024 |
| Project end | September 26, 2027 |
| Funding year | 2026 |
| Award (this year) | $150,359 |
| NIH project number | 3OT2OD037975-01S2 |
| Project ID | NIH-11533814 on NIH RePORTER |
Who could benefit from this research
✓Could help
Potentially interested in or affected by adult-onset diabetes who participate in research data sharing efforts or use insights from large-scale biomedical data.
✕Less likely to help
Patients not involved in or affected by data-sharing platforms may not directly benefit from this project.
What this research studies
This project aims to build a FAIR-compatible platform (SysBio FAIRplex) that makes biomedical data more findable, accessible, interoperable, and reusable for researchers. It will provide a single portal for data discovery, tools for exploration and analysis, and options to work with both harmonized data and original datasets. The effort involves collaboration with established AMP projects and aims to enable larger, multi-cohort insights that could inform healthier lives for people with diabetes and related conditions. The work will be carried out iteratively, with broad activation across workstreams and ongoing stakeholder input.
Why it matters
Potential benefit: If successful, patients could benefit from easier access to integrated research data that accelerates discovery and translation into better diagnostics, treatments, and care for adult-onset diabetes.
How similar studies have gone: This project builds on proven, harmonized data platforms used in AMP and GP2 efforts, indicating a track record of success in data integration for human health.
Where this research is happening
-
Verily Life Sciences LLC
South San Francisco, United States Active
Researchers
- Principal investigator: Skinner, Halcyon G — Verily Life Sciences LLC
- Study coordinator: Skinner, Halcyon G
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.